• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Asian Journal of Animal and Veterinary Advances
  2. Vol 7 (11), 2012
  3. 1148-1156
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Asian Journal of Animal and Veterinary Advances

Year: 2012 | Volume: 7 | Issue: 11 | Page No.: 1148-1156
DOI: 10.3923/ajava.2012.1148.1156

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 190

Authors


Seyedeh Farnaz Ghasemi-Niri

Country: Iran

Sara Solki

Country: Iran

Tina Didari

Country: Iran

Shilan Mozaffari

Country: Iran

Maryam Baeeri

Country: Iran

Mohammad Amin Rezvanfar

Country: Iran

Azadeh Mohammadirad

Country: Iran

Hossein Jamalifar

Country: Iran

Mohammad Abdollahi

Country: Iran

Keywords


  • myeloperoxidase (MPO)
  • Saccharomyces boulardii
  • Lactobacillus casei
  • ulcerative colitis
  • Bifidobacterium bifidum
  • tumor necrosis factor alpha (TNF-a)
Research Article

Better Efficacy of Lactobacillus casei in Combination with Bifidobacterium bifidum or Saccharomyces boulardii in Recovery of Inflammatory Markers of Colitis in Rat

Seyedeh Farnaz Ghasemi-Niri, Sara Solki, Tina Didari, Shilan Mozaffari, Maryam Baeeri, Mohammad Amin Rezvanfar, Azadeh Mohammadirad, Hossein Jamalifar and Mohammad Abdollahi
Alteration of intestinal microflora has an important role in Inflammatory Bowel Disease (IBD) and probiotics by balancing microflora and modulating inflammatory cytokines seem effective in management of IBD. In the present study, two combinations of probiotics Lactobacillus casei (L. casei) plus Bifidobacterium bifidum (B. bifidum) or plus Saccharomyces boulardii (S. boulardii) were tested for their potential to prevent or treat experimental colitis in rats. Nine groups of animals including sham (normal group), control (vehicle-treated), dexamethasone as standard, treatment groups (oral administration of L. casei and mixture of (L. casei-B. bifidum and L. casei-S. boulardii after induction of colitis) and prevention groups (oral administrations of L. casei and mixture of (L. casei-B. bifidum and L. casei-S. boulardii before induction of colitis) were used. Tumor necrosis factor-α (TNF-α), myeloperoxidase (MPO) and lipid peroxidation (LPO) were determined in all groups. In treatment groups, histological scores and TNF-α, MPO and LPO levels attenuated significantly but colonic lesions in the prevention groups did not recover. The results revealed that, combination of L. casei-B. bifidum and L. casei-S. boulardii alleviated inflammatory parameters in colitis but these combinations were ineffective to prevent colitis. In addition, we found that mixture of probiotics is significantly more effective than L. casei group in improving barrier function of epithelium in experimental colitis model.
PDF Fulltext XML References Citation

How to cite this article

Seyedeh Farnaz Ghasemi-Niri, Sara Solki, Tina Didari, Shilan Mozaffari, Maryam Baeeri, Mohammad Amin Rezvanfar, Azadeh Mohammadirad, Hossein Jamalifar and Mohammad Abdollahi, 2012. Better Efficacy of Lactobacillus casei in Combination with Bifidobacterium bifidum or Saccharomyces boulardii in Recovery of Inflammatory Markers of Colitis in Rat. Asian Journal of Animal and Veterinary Advances, 7: 1148-1156.

DOI: 10.3923/ajava.2012.1148.1156

URL: https://scialert.net/abstract/?doi=ajava.2012.1148.1156

Related Articles

A Review and Meta-analysis of the Efficacy of Antibiotics and Probiotics in Management of Pouchitis

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved